Shape Therapeutics logo

Shape Therapeutics

startupfundraising.com

Shape Therapeutics develops programmable RNA medicines that use AI and RNA technology to address genetic causes of disease. Its work includes RNA editing, next-generation AAV delivery and gene therapy manufacturing for pharmaceutical innovators developing treatments for rare genetic disorders and other diseases.

Facts

HQ
Seattle, Washington, US
Sectors
Biotechnology Research
Founded
2018
Type
Corporation Seattle business license
Employees
51–200
Registered name
Shape Therapeutics Inc Seattle business license
Stage
Series B

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Shape Therapeutics

See all 7

Flexe hires Amazon biometrics lead Lara Rogers as SVP/GM; Magnify names ex‑Amazon Sajo Jacob CTO; Schuster joins Open Systems board

Several Seattle-area tech companies announced senior hires and board moves: Flexe hired former Amazon biometrics leader Lara Rogers as SVP and GM; Magnify named Sajo Jacob as CTO and co‑founder after a $6M launch; Open Systems added ex‑Microsoft exec Gavriella Schuster to its board; Fabric and Scener also announced senior appointments.

CBRE: U.S. life-sciences VC tops $30B; Seattle-area firms raise $898M amid scarce lab space

A CBRE report shows U.S. life sciences venture funding topped $30 billion for the 12 months ending September 2021, driving strong demand for lab space and record capital raises in Seattle-area companies that pulled in $898 million during that period. Washington state also saw rising life-science employment and multiple biotech IPOs in 2021, including large offerings from Sana Biotechnology, Absci and Icosavax.

Shape Therapeutics raises $112M to advance RNA-editing platform and AAV gene-delivery for neurological and genetic diseases

Seattle preclinical biotech Shape Therapeutics raised $112 million to develop RNA-editing and gene therapy technologies, including improved AAV delivery vectors and an RNA editing platform. The company, led by CEO and co-founder Francois Vigneault and leveraging work from co-founder Prashant Mali, aims to target neurological and genetic diseases such as Parkinson's, Alzheimer’s, alpha-1 antitrypsin deficiency, and Rett syndrome.

By Shape Therapeutics

Shape Therapeutics and Rett Syndrome Research Trust partner to advance SHP-401 AI-designed RNAfix® therapy correcting MECP2 R168X toward IND studies

Shape Therapeutics and the Rett Syndrome Research Trust partnered to fund translational studies of SHP-401, an intravenously delivered, one-time RNAfix® gene therapy using AI-designed guide RNA to correct the MECP2 R168X mutation for Rett syndrome. Preclinical mouse data posted to bioRxiv show ~70% RNA editing in the brain and restoration of full-length MeCP2 after a single IV dose, supporting IND-enabling study goals in non-human primates.

People

  • David Huss Executive, Chief Scientific Officer and Interim CEO
  • Francois Vigneault Former founder

Online

Questions about Shape Therapeutics

What is Shape Therapeutics?

Shape Therapeutics is a startup based in Seattle, Washington, US that develops programmable RNA medicines using AI and RNA technology to address genetic causes of disease.

What is Shape Therapeutics known for?

Shape Therapeutics works on RNA editing, next-generation AAV delivery and gene therapy manufacturing for pharmaceutical innovators developing treatments for rare genetic disorders and other diseases.

What has Shape Therapeutics been in the news for?

GeekWire reported in July 2021 on Shape Therapeutics’ efforts to advance its RNA-editing platform and AAV gene delivery for neurological and genetic diseases.

Who are the people behind Shape Therapeutics?

David Huss is an executive, chief scientific officer and interim CEO at Shape Therapeutics.

Who invested in Shape Therapeutics, and how much has it raised?

Members of Seattle Flow see Shape Therapeutics' funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Shape Therapeutics based?

Shape Therapeutics is based in Seattle, Washington, US.